Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-23

Integrated in vitro and in vivo testing of drugs in prion diseases: screening, development and mechanisms of novel therapeutics

Objective

Developing therapeutic strategies for Tees is of great public concern, especially since the advent of variant CJD. We will examine, in a comprehensive and integrate-ed manner, novel candidate drugs targeting different key events in infected pathogen-sis. We will identify compounds that disrupt the structure of prisons (reducing infectivity), inhibit Preps production &/or prevent Induced-induced neurotoxicity. The compounds will then be tested for their ability to inhibit infected replication in lymphoid tissues, block neuroinvasion, inhibit establishment of infection in the CNS &/or retard pathological changes in the brain that lead to clinical disease. These objectives will be attained through combined high throughput in vitro screening systems & defined animal models. Insights into mechanisms of infected disease pathogenesis will be obtained. The outcome will be named compounds that could be used to treat TSE disease in man or inactivate infectivity in biomedical products.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Topic(s)

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

UNIVERSITY OF GLASGOW
EU contribution
No data
Address
Bearsden
G61 1QH GLASGOW
United Kingdom
Total cost
No data

Participants (5)